TABLE 1.

Susceptibility profiles of different P. aeruginosa isolates used in the study

Isolate	MIC (μg/ml)a
	TZP	ATM	CRO	FEP	CAZ	C/T	IPM	MEM	CIP	MXF	TOB	GEN	AMK	TGC	MIN	CST
PAO1b	8	4	ND	ND	2	0.5	ND	1	0.125	1	1	1	ND	4	8	1
PA100036	8	16	32	4	8	0.5	8	4	>16	>16	128	>32	32	32	16	2
PA101885	16	16	32	8	8	0.5	1	4	>16	>16	1	≤0.5	≤1	8	8	1
PA259-96918c	64	32	>64	>64	512	>16	32	512	>16	>16	256	>32	>64	32	32	1
PA260-97103	128	64	>64	16	32	1	32	16	16	>16	32	>32	4	16	16	1
PA262-101856	64	32	64	32	16	1	32	32	>16	>16	1024	>32	>64	32	64	1
PA264-104354	256	64	>64	32	128	2	32	64	>16	>16	128	>32	8	32	32	1
PA91433	64	512	>64	16	1024	0.5	32	16	2	16	16	32	>32	32	16	4
PA101243	128	32	>64	64	64	1	16	16	1	8	128	>32	>64	ND	2	1024
PA86052	256	64	>64	32	64	2	32	16	>16	>16	1	4	16	ND	ND	1
PA88949	256	32	>64	32	64	2	>32	16	4	8	4	16	32	ND	ND	2
PA107092	512	64	>64	64	128	2	32	32	>16	>16	>64	>32	8	ND	ND	1
PA108590	256	32	>64	32	32	2	32	16	4	16	4	16	32	ND	ND	1
PA109084	512	64	>64	32	64	2	32	16	4	16	4	16	32	ND	ND	1

^aTZP, piperacillin-tazobactam; ATM, aztreonam; CRO, ceftriaxone; FEP, cefepime; CAZ, ceftazidime; C/T, ceftolozane-tazobactam; IPM, imipenem; MEM, meropenem; CIP, ciprofloxacin; MXF, moxifloxacin; TOB, tobramycin; GEN, gentamicin; AMK, amikacin; TGC, tigecycline; MIN, minocycline; CST, colistin; ND, not determined.

^bWild type.

^cMBL-producing.